| Autor: |
Webster, CM, Hokari, M, McManus, A, Tang, XN, Ma, H, Kacimi, R, Yenari, MA |
| Jazyk: |
angličtina |
| Rok vydání: |
2013 |
| Předmět: |
|
| Zdroj: |
Webster, CM; Hokari, M; McManus, A; Tang, XN; Ma, H; Kacimi, R; et al.(2013). Microglial P2Y12 Deficiency/Inhibition Protects against Brain Ischemia. PLoS ONE, 8(8). doi: 10.1371/journal.pone.0070927. UCSF: Retrieved from: http://www.escholarship.org/uc/item/98p4b2q3 |
| DOI: |
10.1371/journal.pone.0070927. |
| Popis: |
Objective:Microglia are among the first immune cells to respond to ischemic insults. Triggering of this inflammatory response may involve the microglial purinergic GPCR, P2Y12, activation via extracellular release of nucleotides from injured cells. It is also the inhibitory target of the widely used antiplatelet drug, clopidogrel. Thus, inhibiting this GPCR in microglia should inhibit microglial mediated neurotoxicity following ischemic brain injury.Methods:Experimental cerebral ischemia was induced, in vitro with oxygen-glucose deprivation (OGD), or in vivo via bilateral common carotid artery occlusion (BCCAO). Genetic knock-down in vitro via siRNA, or in vivo P2Y12 transgenic mice (P2Y12-/- or P2Y12+/-), or in vivo treatment with clopidogrel, were used to manipulate the receptor. Neuron death, microglial activation, and microglial migration were assessed.Results:The addition of microglia to neuron-astrocyte cultures increases neurotoxicity following OGD, which is mitigated by microglial P2Y12 deficiency (P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
